Literature DB >> 17702733

Pain, sleep disturbance, and quality of life in patients with chronic kidney disease.

Scott D Cohen1, Samir S Patel, Prashant Khetpal, Rolf A Peterson, Paul L Kimmel.   

Abstract

BACKGROUND AND OBJECTIVES: Few studies have assessed sleep disturbances or perception of pain in patients with early-stage chronic kidney disease. It was hypothesized that perception of pain and sleep disturbance would increase with chronic kidney disease stage, that pain and sleep disturbance would correlate with psychosocial variables, and that there would be a higher prevalence of pain and sleep disturbances in patients with chronic kidney disease compared with general medical patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 92 predialysis patients with chronic kidney disease and 61 general medical outpatients were evaluated using the Beck Depression Inventory, Illness Effects Questionnaire, Multidimensional Scale of Perceived Social Support, Satisfaction with Life Scale, Karnofsky Scale, Pittsburgh Sleep Questionnaire, and McGill Pain questionnaire.
RESULTS: With the exception of expected differences in serum creatinine, estimated GFR, Karnofsky score, albumin, and hemoglobin, there were no significant differences between groups. A total of 69% of patients with chronic kidney disease experienced pain; 55.2% had disordered sleep. Pain was associated with quality-of-life indicators, including depression, burden of illness, and life satisfaction. Disordered sleep correlated with depression, illness burden, social support, and pain frequency. There were no differences in perception of pain or sleep disturbance between patients with chronic kidney disease and control patients.
CONCLUSIONS: Pain is common in patients with early-stage chronic kidney disease and is associated with patients' perception of lower quality of life. The prevalence of pain, sleep disturbance, and abnormal psychologic status of patients with chronic kidney disease may be similar to outpatients with other chronic medical illnesses.

Entities:  

Mesh:

Year:  2007        PMID: 17702733     DOI: 10.2215/CJN.00820207

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  51 in total

1.  Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease.

Authors:  Michael J Fischer; Paul L Kimmel; Tom Greene; Jennifer J Gassman; Xuelei Wang; Deborah H Brooks; Jeanne Charleston; Donna Dowie; Denyse Thornley-Brown; Lisa A Cooper; Marino A Bruce; John W Kusek; Keith C Norris; James P Lash
Journal:  Kidney Int       Date:  2011-06-01       Impact factor: 10.612

Review 2.  Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence.

Authors:  Nicolas F Turek; Ana C Ricardo; James P Lash
Journal:  Am J Kidney Dis       Date:  2012-06-21       Impact factor: 8.860

3.  Performance of depression rating scales in patients with chronic kidney disease: an item response theory-based analysis.

Authors:  Marisa Toups; Thomas Carmody; Madhukar H Trivedi; A John Rush; S Susan Hedayati
Journal:  Gen Hosp Psychiatry       Date:  2016-07-25       Impact factor: 3.238

4.  Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure.

Authors:  Sara N Davison
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-04       Impact factor: 8.237

5.  The relation of trouble sleeping, depressed mood, pain, and fatigue in patients with cancer.

Authors:  Edward J Stepanski; Mark S Walker; Lee S Schwartzberg; L Johnetta Blakely; Jason C Ong; Arthur C Houts
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

Review 6.  Health-related quality of life outcomes in chronic kidney disease.

Authors:  Ritu K Soni; Steven D Weisbord; Mark L Unruh
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-03       Impact factor: 2.894

7.  Prevalence of major depressive episode in CKD.

Authors:  S Susan Hedayati; Abu T Minhajuddin; Robert D Toto; David W Morris; A John Rush
Journal:  Am J Kidney Dis       Date:  2009-06-03       Impact factor: 8.860

8.  Validation of depression screening scales in patients with CKD.

Authors:  S Susan Hedayati; Abu T Minhajuddin; Robert D Toto; David W Morris; A John Rush
Journal:  Am J Kidney Dis       Date:  2009-06-03       Impact factor: 8.860

9.  Satisfaction with Life in Orofacial Pain Disorders: Associations and Theoretical Implications.

Authors:  Ian A Boggero; Marcia V Rojas-Ramirez; Reny de Leeuw; Charles R Carlson
Journal:  J Oral Facial Pain Headache       Date:  2016

10.  Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector.

Authors:  Willem P Meuwesen; Jesslee M du Plessis; Johanita R Burger; Martie S Lubbe; Marike Cockeran
Journal:  Int J Clin Pharm       Date:  2016-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.